SST and medullary thyroid gland carcinoma: For treatment of metastatic MTC, it is of value to investigate the efficiency of the combination of gemcitabine and radiation, both as EBRT and as systemic radionuclide therapy using radiolabelled SST analogues, e. g. 177Lu-octreotate.